Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer

OBJECTIVE: Galunisertib (LY2157299 monohydrate), an inhibitor of the transforming growth factor β (TGFβ) pathway, is currently under investigation in several clinical trials involving multiple tumor types. The primary objective of this study was to assess relative bioavailability of two new galunise...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drugs Context
Main Authors: Gueorguieva, Ivelina, Cleverly, Ann, Desaiah, Durisala, Azaro, Analia, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Miles, Colin, Lahn, Michael M, Mitchell, Malcolm I, Rodon, Jordi
Format: Artigo
Sprog:Inglês
Udgivet: Just Medical Media Limited 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5147053/
https://ncbi.nlm.nih.gov/pubmed/27990167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212303
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker